Last reviewed · How we verify
NCT04076982: MungBean
Effect of Supplementary Dietary Protein (21g Per Day) on Lean Mass and Strength in Sedentary, Adult Vegetarians
NA trial testing mung bean protein in Muscle Weakness in 37 participants. Completed in 12 January 2019.
12 January 2019
Quick facts
| Lead sponsor | Arizona State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | other |
| Enrollment | 37 |
| Start date | 3 September 2018 |
| Primary completion | 12 January 2019 |
| Estimated completion | 12 January 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- mung bean protein
- control biscuit
Conditions studied
- Muscle Weakness — all drugs for Muscle Weakness →
Sponsor
Arizona State University
Who can join
Adults 18 to 55, any sex, with Muscle Weakness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is possible that the lower protein intake in vegetarians and vegans may relate to a decrease in grip strength. Furthermore, there is limited research examining the effects of plant-based protein intake on strength and LBM independent of an exercise training component. The present study was designed to examine relationships between strength, protein intake, and LBM in underactive vegetarian and vegan adults, as well as the impact of protein supplementation (18 g mung bean protein daily) on these indices.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04076982
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Muscle Weakness
Currently open trials in the same condition.
- NCT06998134 — Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults · recruiting
- NCT07103499 — Abdominal and Core Exercises on Respiratory Functions in Obese and Overweight Women (COREBREATH) · NA · recruiting
- NCT07292311 — Reliability of Muscle Strength and Activation Assessment Tools and Effects of an Online Therapeutic Exercise Program in · NA · active not recruiting
- NCT07026084 — Effects of Biofeedback-Guided Training on Muscle Strength and Postural Alignment in Upper Cross Syndrome. · NA · recruiting
- NCT06205147 — Effects of Elastic Band Resistance Exercise on Muscle Strength and Depression in Hospitalized Elderly. · NA · recruiting
Other Arizona State University trials
Trials by the same sponsor.
- NCT07519408 — Acute Kidney Injury and Ultra-endurance Running · NA · not yet recruiting
- NCT05784467 — Methamphetamine, PrEP, and Intersectional Stigma Study · NA · not yet recruiting
- NCT07375043 — Drumming Groups for Parents of Autistic Children · NA · not yet recruiting
- NCT07297901 — App-based Breathing Program for Migraine Relief · NA · enrolling by invitation
- NCT06721793 — The Impact of a Caffeinated Sports Drink on Performance · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04076982 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arizona State University
- Last refreshed: 4 September 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04076982.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing